Therapeutic aspects of cannabis and cannabinoids

British Journal of Psychiatry

Volumn 178, Issue FEB., 2001, Pages 107-115

  Robson, P ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTHMA; BLOOD PRESSURE REGULATION; DRUG DEPENDENCE; EPILEPSY; HUMAN; INSOMNIA; INTRAOCULAR PRESSURE; PAIN; RISK ASSESSMENT; WELLBEING;

ANALGESICS, NON-NARCOTIC; APPETITE; CANNABINOIDS; CANNABIS; EPILEPSY; GOVERNMENT AGENCIES; GREAT BRITAIN; HUMANS; LEGISLATION, DRUG; MALE; MULTIPLE SCLEROSIS; NAUSEA; PHYTOTHERAPY;

EID: 0035135376     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.178.2.107     Document Type: Article

References (57)

1. An efficient new cannabinoid anti-emetic in pediatric oncology
2. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
3. Hypnotic and antiepileptic effects of cannabidiol
4. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: A double-blind, crossover trial
5. Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation
6. The quasimorphine withdrawal syndrome: Effect of cannabinol, cannabidiol and THC
7. Tetrahydrocannabinol for tremor in multiple sclerosis
8. Anticonvulsant nature of marihuana smoking
9. Controlled clinical trial of cannabidiol in Huntington's disease
10. The perceived effects of smoked cannabis on patients with multiple sclerosis
11. Chronic administration of cannabidiol to healthy volunteers and epileptic patients
12. Nabilone: An alternative antiemetic for cancer chemotherapy
13. Marijuana as anti-emetic medicine: A survey of oncologists' experiences and attitudes
14. Nabilone: An effective antiemetic in patients receiving cancer chemotherapy
15. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety
16. Behavioral analysis of marijuana effects on food intake in humans
17. The medicinal use of cannabis and its constituents
18. Short term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers
19. A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa
20. Antitumor properties of cannabinoids
21. The ocular effects of marihuana smoking
22. Pain relief with oral cannabinoids in familial Mediterranean fever
23. Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine
24. Nabilone, a cannabinol derivative, in the treatment of anxiety neuroses
25. Cannabinoids and animal physiology
26. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain
27. Clinical relevance of cannabis tolerance and dependence
28. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting
29. No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals
30. Grand mal convulsions subsequent to marihuana use
31. Dronabinol and prochlorperazine in combination are better than either agent alone for treatment of chemotherapy-induced nausea and vomiting
32. Cannabinoids as antiemetics in cancer chemotherapy
33. Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial
34. The pharmacohistory of Cannabis sativa
35. Doctors want cannabis prescriptions allowed
36. Effect of marihuana on intraocular and blood pressure in glaucoma
37. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas
38. Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy
39. A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy
40. Analgesic effect of delta-9-tetrahydrocannabinol
41. The analgesic properties of delta-9-tetrahydrocannabinol and codeine
42. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine
43. Clinical trials with anti-emetic agents in cancer patients receiving chemotherapy
44. Intravenous administration of cannabinoids and intraocular pressure
45. Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: An overview
46. Treatment of human spasticity with delta-9-tetrahydrocannabinol
47. Recent clinical experience with dronabinol
48. Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis
49. Delta-9-THC as an effective antidepressant and appetite-stimulating agent in advanced cancer patients
50. Therapeutic uses and toxic effects of cannabis indica
51. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy
52. Bronchial effects of aerosolized delta-9-THC in healthy and asthmatic subjects
53. Cannabis and cancer chemotherapy: A comparison of oral delta-9-THC and prochlorperazine
54. Delta-9-THC in the treatment of spasticity associated with multiple sclerosis